Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ECOR NASDAQ:IRIX NASDAQ:LNSR NASDAQ:NYXH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECORelectroCore$8.77$7.86$4.16▼$10.49$72.79M0.8891,212 shs54,308 shsIRIXIRIDEX$1.13$1.09$0.87▼$1.65$19.67M0.6338,370 shs27,467 shsLNSRLENSAR$6.40$5.74$5.06▼$13.47$78.59M0.87116,751 shs130,550 shsNYXHNyxoah$1.72$2.39$1.26▼$8.59$66.67M1.61607,377 shs110,361 shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECORelectroCore0.00%+11.86%+0.57%+24.57%+45.44%IRIXIRIDEX0.00%0.00%+3.67%+13.39%+23.36%LNSRLENSAR0.00%+13.27%+14.29%+8.66%-51.47%NYXHNyxoah0.00%+2.99%+18.62%-50.86%-77.86%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECORelectroCore$8.77$7.86$4.16▼$10.49$72.79M0.8891,212 shs54,308 shsIRIXIRIDEX$1.13$1.09$0.87▼$1.65$19.67M0.6338,370 shs27,467 shsLNSRLENSAR$6.40$5.74$5.06▼$13.47$78.59M0.87116,751 shs130,550 shsNYXHNyxoah$1.72$2.39$1.26▼$8.59$66.67M1.61607,377 shs110,361 shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECORelectroCore0.00%+11.86%+0.57%+24.57%+45.44%IRIXIRIDEX0.00%0.00%+3.67%+13.39%+23.36%LNSRLENSAR0.00%+13.27%+14.29%+8.66%-51.47%NYXHNyxoah0.00%+2.99%+18.62%-50.86%-77.86%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceECORelectroCore 2.00Hold$18.00105.25% UpsideIRIXIRIDEX 2.00Hold$3.00165.49% UpsideLNSRLENSAR 2.33Hold$10.0056.25% UpsideNYXHNyxoah 2.25Hold$7.00306.98% UpsideCurrent Analyst Ratings BreakdownLatest IRIX, LNSR, NYXH, and ECOR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/1/2026IRIXIRIDEX Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/24/2026ECORelectroCore Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)6/17/2026NYXHNyxoah Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$5.00 ➝ $3.006/16/2026IRIXIRIDEX Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/2/2026IRIXIRIDEX Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/22/2026NYXHNyxoah Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/19/2026IRIXIRIDEX Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/13/2026NYXHNyxoah Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$9.00 ➝ $7.005/12/2026NYXHNyxoah Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy ➝ Hold$8.00 ➝ $5.005/11/2026LNSRLENSAR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Sell (D+)5/11/2026NYXHNyxoah Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)(Data available from 7/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookECORelectroCore$32.03M2.27N/AN/A($0.21) per share-41.76IRIXIRIDEX$52.67M0.37N/AN/A($0.06) per share-18.83LNSRLENSAR$58.44M1.34N/AN/A($2.18) per share-2.94NYXHNyxoah$11.33M5.88N/AN/A$1.43 per share1.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateECORelectroCore-$13.97M-$1.77N/AN/AN/A-44.08%-1,956.38%-83.30%8/5/2026 (Estimated)IRIXIRIDEX-$4.44M-$0.19N/AN/AN/A-6.23%N/A-11.16%8/6/2026 (Estimated)LNSRLENSAR-$34.28M-$0.58N/AN/AN/A50.94%-183.19%42.26%8/6/2026 (Estimated)NYXHNyxoah-$101.92M-$2.48N/AN/AN/A-543.21%-163.73%-80.24%8/5/2026 (Estimated)Latest IRIX, LNSR, NYXH, and ECOR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2026Q1 2026IRIXIRIDEX-$0.07-$0.03+$0.04-$0.03$11.91 million$11.80 million5/12/2026Q1 2026NYXHNyxoah-$0.54-$0.43+$0.11-$0.43$7.05 million$7.38 million5/8/2026Q1 2026LNSRLENSAR$0.1850$1.56+$1.3750N/A$13.40 million$13.43 million5/6/2026Q1 2026ECORelectroCore-$0.59-$0.59N/A-$0.59$9.01 million$9.58 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthECORelectroCoreN/AN/AN/AN/AN/AIRIXIRIDEXN/AN/AN/AN/AN/ALNSRLENSARN/AN/AN/AN/AN/ANYXHNyxoahN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioECORelectroCoreN/A1.020.86IRIXIRIDEXN/A1.921.19LNSRLENSARN/A2.381.08NYXHNyxoah0.530.990.88Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipECORelectroCore26.74%IRIXIRIDEX20.10%LNSRLENSAR40.15%NYXHNyxoahN/AInsider OwnershipCompanyInsider OwnershipECORelectroCore13.80%IRIXIRIDEX8.60%LNSRLENSAR65.80%NYXHNyxoahN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableECORelectroCore508.30 million7.15 millionNot OptionableIRIXIRIDEX12017.41 million15.91 millionOptionableLNSRLENSAR11012.28 million4.20 millionOptionableNYXHNyxoah11038.76 millionN/ANot OptionableIRIX, LNSR, NYXH, and ECOR HeadlinesRecent News About These CompaniesContrasting Nyxoah (NASDAQ:NYXH) and HeartBeam (NASDAQ:BEAT)July 1, 2026 | americanbankingnews.comInformation on the total number of voting rights and sharesJune 30, 2026 | globenewswire.comPublication relating to transparency notificationsJune 29, 2026 | globenewswire.comNyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital ConcernsJune 24, 2026 | finance.yahoo.comNyxoah to Host Investor Day in New York on July 8, 2026June 23, 2026 | globenewswire.comNyxoah (NYXH) Gets a Hold from Stifel NicolausJune 23, 2026 | theglobeandmail.comInvitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 9 juillet 2026June 19, 2026 | globenewswire.comInvitation to attend the extraordinary shareholders' meeting of the Company to be held on July 9, 2026June 19, 2026 | globenewswire.comPublication relating to transparency notificationsJune 17, 2026 | globenewswire.comNyxoah Receives $15 Million from the European Investment BankJune 17, 2026 | globenewswire.comNyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical TechnologyJune 16, 2026 | finance.yahoo.comInformation on the total number of voting rights and sharesJune 10, 2026 | globenewswire.com$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial LaunchJune 10, 2026 | globenewswire.comNyxoah Announces Closing of Underwritten Public OfferingJune 10, 2026 | globenewswire.comWhat's going on with Nyxoah stock Tuesday?June 9, 2026 | msn.comNyxoah Launches $88.5 Million Underwritten Share Offering to Fund Genio OSA ExpansionJune 8, 2026 | tipranks.comWhy is NYXH stock falling today?June 5, 2026 | msn.comNyxoah Announces Pricing of $95 Million Underwritten Public OfferingJune 5, 2026 | globenewswire.comNyxoah Announces Proposed Offering of Ordinary SharesJune 4, 2026 | globenewswire.comNyxoah Enters New Chapter of Long Term Value CreationJune 4, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIRIX, LNSR, NYXH, and ECOR Company DescriptionselectroCore NASDAQ:ECOR$8.77 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$8.55 -0.22 (-2.51%) As of 07/2/2026 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.IRIDEX NASDAQ:IRIX$1.13 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$1.13 +0.00 (+0.35%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.LENSAR NASDAQ:LNSR$6.40 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$6.43 +0.03 (+0.47%) As of 07:40 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.Nyxoah NASDAQ:NYXH$1.72 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$1.87 +0.15 (+8.72%) As of 08:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/29 - 07/03 Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst This Under-the-Radar Industrial Is Quietly Powering AI SanDisk’s Volatility May Be Telling Bulls What They Want to Hear Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential Why the Comcast Spin-Off Won't Fix What's Actually Broken Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
